InsiderTrades

Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-21 · accession 0001209191-23-059715 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2023-12-26 2023-12-21+ ELVN Heyman Richard A. Dir S - Sale $13.00 -175 147.4K -0.1% -$2,275
MI 2023-12-26 2023-12-21+ ELVN Heyman Richard A. Dir S - Sale $13.00 -41 29.3K -0.1% -$533

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-22 S D 168 $13.00 147,280 D — —
2 Common Common Stock 2023-12-22 S D 35 $13.00 29,216 I — —
3 Common Common Stock 2023-12-21 S D 7 $13.00 147,448 D See footnote — — (F2) The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.
4 Common Common Stock 2023-12-21 S D 6 $13.00 29,251 I See footnote — — (F2) The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.